Clinical Trials Directory

Trials / Completed

CompletedNCT03934710

Mood Effects of Serotonin Agonists Extended

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
56 (actual)
Sponsor
University of Chicago · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

In this study we are examining the effects of repeated very low doses of serotonin agonists on mood individuals with negative mood.

Detailed description

Here, we are examining the effects of four repeated low doses of lysergic acid diethylamide (LSD), compared to placebo, administered to healthy adults at 3-4 day intervals, on mood, cognitive performance and responses to emotional tasks

Conditions

Interventions

TypeNameDescription
DRUGPlaceboDrug will be administered in solution form
DRUGSerotonin agonist - 13ug13ug lysergic acid diethylamide
DRUGSerotonin agonist - 26ug26ug lysergic acid diethylamide

Timeline

Start date
2019-04-20
Primary completion
2021-06-07
Completion
2021-06-07
First posted
2019-05-02
Last updated
2023-11-29
Results posted
2023-11-29

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03934710. Inclusion in this directory is not an endorsement.

Mood Effects of Serotonin Agonists Extended (NCT03934710) · Clinical Trials Directory